Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
8.70
-0.13 (-1.51%)
Mar 25, 2025, 4:00 PM EST - Market closed
Pharming Group Employees
Pharming Group had 382 employees as of December 31, 2023. The number of employees increased by 50 or 15.06% compared to the previous year.
Employees
382
Change (1Y)
50
Growth (1Y)
15.06%
Revenue / Employee
$778,010
Profits / Employee
-$28,866
Market Cap
598.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PHAR News
- 12 days ago - Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Pharming Group reports fourth quarter and full year 2024 financial results and provides business update - GlobeNewsWire
- 21 days ago - Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders - GlobeNewsWire
- 6 weeks ago - Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period - GlobeNewsWire
- 2 months ago - Pharming Group to convene Extraordinary General Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer - GlobeNewsWire
- 3 months ago - Pharming announces public cash offer to the shareholders of Abliva AB - GlobeNewsWire
- 3 months ago - European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug - Benzinga